IPP Bureau
BlueRock Therapeutics Phase I clinical trial for Parkinson’s disease continues to show positive trends
By IPP Bureau - March 06, 2024
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
Sumitomo Corporation launches new refrigerated ocean transportation service
By IPP Bureau - March 05, 2024
Connecting new production and consumption areas of chilled food by low-carbon transportation services
KIMS Hospitals to acquire land on 99-year lease to set up new hospital at Thane
By IPP Bureau - March 05, 2024
The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore
Biocon Biologics secures Canada market entry date for YESAFILI
By IPP Bureau - March 05, 2024
This agreement paves the way for the introduction of YESAFILI into the Canadian market
Dr Mandaviya launches AYUSH-ICMR Advanced Centre for Integrated Health Research in AIIMS
By IPP Bureau - March 05, 2024
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
18% of India's population needs assistive care, says former DGHS
By IPP Bureau - March 05, 2024
Govt. setting up of Ayush - ICMR Advanced Centre for AI-ACIHR at select AIIMS
By IPP Bureau - March 04, 2024
Launch of Indian public health standards for Ayush healthcare facilities
Health Minister Mandaviya inaugurates 27 greenfield bulk drug park, 13 medical device manufacturing plants
By IPP Bureau - March 04, 2024
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
Dr. Mandaviya addresses Governing Council Meeting of the ICMR
By IPP Bureau - March 04, 2024
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Ami Organics granted patent
By IPP Bureau - March 04, 2024
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Briefs: SMS Pharmaceuticals and Vimta Labs
By IPP Bureau - March 03, 2024
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease
By IPP Bureau - March 03, 2024
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
USFDA inspects Shilpa Medicare’s bio-analytical laboratory in Hyderabad
By IPP Bureau - March 02, 2024
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
Aurobindo Pharma receives USFDA approval for Fingolimod Capsules, 0.5 mg
By IPP Bureau - March 02, 2024
The product will be launched in March 2024
